HLA expression tied to penile cancer outcomes

April 20, 2015

HLA expression tied to penile cancer outcomes
(HealthDay)—Human leukocyte antigen (HLA) expression appears to be tied to clinical outcomes in penile cancer, according to a study published in the April issue of The Journal of Urology.

Rosa S. Djajadiningrat, M.D., from the Netherlands Cancer Institute in Amsterdam, and colleagues constructed tissue microarrays from tissue blocks from 168 patients who underwent surgical resection between 2000 and 2009. HLA expression was determined using immunohistochemical staining (using classic and nonclassic molecules), and expression was scored semiquantitatively.

The researchers found that complete and partial loss of total classic HLA class I were seen in 32 and 50 percent of cases, respectively. Up-regulation of HLA-E and G was seen in 16 and 13 percent, respectively. Partial HLA-A loss was significantly associated with decreased survival overall (hazard ratio, 2.3) and in human papillomavirus-negative patients alone (hazard ratio, 3.4), when adjusting for relevant clinical parameters. Survival was not tied to abnormal HLA-B/C, E, or G .

"Complete understanding of the mechanisms and relevance of HLA down-regulation and immune evasion in regard to the clinical outcome will contribute to the future design of immunotherapy interventions," the authors write.

Explore further: Aspirin use appears linked with improved survival after colon cancer diagnosis

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Aspirin use appears linked with improved survival after colon cancer diagnosis

March 31, 2014
Taking low doses of aspirin (which inhibits platelet function) after a colon cancer diagnosis appears to be associated with better survival if the tumor cells express HLA class I antigen.

New study challenges link between HLA class I hyperexpression in pancreas and type 1 diabetes

January 6, 2015
The cause of type 1 diabetes remains unknown. Several studies using immunohistochemistry (IHC) have independently reported hyperexpression of human leukocyte antigen (HLA) class I on pancreatic islet cells in young patients ...

Particular donor genotype lowers leukemia relapse rate

August 30, 2012
(HealthDay)—Patients with acute myeloid leukemia who receive a stem cell transplant from a donor with activating killer-cell immunoglobulin-like receptor (KIR) genotype KIR2DS1, which has ligand specificity for human leukocyte ...

An unusual version of a gene appears to protect against enteric fever

April 15, 2015
A study looking for links between genes and susceptibility to enteric fever has found that people who carry a specific version of a gene are nearly five times less likely to have the disease. This finding by an A*STAR-led ...

New research shows how aspirin may act on blood platelets to improve survival in colon cancer patients

September 30, 2013
Researchers believe they have discovered how aspirin improves survival in patients diagnosed with colon cancer, the 2013 European Cancer Congress (ECC2013) [1] heard today (Monday).

Transplant success tied to naturally high levels of powerful immune molecule package

April 28, 2014
Patients with highest levels of the most powerful version of the immune molecule HLA-G appear to have the lowest risk of rejecting their transplanted kidney, researchers report.

Recommended for you

Researchers identify a mechanism that fuels cancer cells' growth

November 14, 2018
Scientists at the UCLA Jonsson Comprehensive Cancer Center have identified sodium glucose transporter 2, or SGLT2, as a mechanism that lung cancer cells can utilize to obtain glucose, which is key to their survival and promotes ...

A new approach to detecting cancer earlier from blood tests: study

November 14, 2018
Cancer scientists led by principal investigator Dr. Daniel De Carvalho at Princess Margaret Cancer Centre have combined "liquid biopsy", epigenetic alterations and machine learning to develop a blood test to detect and classify ...

New antibody breakthrough to lead the fight against cancer

November 14, 2018
Scientists at the University of Southampton have developed a new antibody that could hold the key to unlocking cancer's defence against the body's immune system.

Photoacoustic imaging may help doctors detect ovarian tumors earlier

November 14, 2018
Ovarian cancer claims the lives of more than 14,000 in the U.S. each year, ranking fifth among cancer deaths in women. A multidisciplinary team at Washington University in St. Louis has found an innovative way to use sound ...

Solving the mystery of NPM1 in acute myeloid leukemia

November 13, 2018
Although it has long been recognized that mutations of gene NPM1 play an important role in acute myeloid leukemia, no one has determined how the normal and the mutated forms of the protein NPM1 function.

Cognitive decline—radiation—brain tumor prevented by temporarily shutting down immune response

November 13, 2018
Treating brain tumors comes at a steep cost, especially for children. More than half of patients who endure radiation therapy for these tumors experience irreversible cognitive decline, a side-effect that has particularly ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.